EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Trends in atherogenic risk associated with different lipoprotein phenotypes in relation to age



Trends in atherogenic risk associated with different lipoprotein phenotypes in relation to age



European Heart Journal 22(Abstract Supplement): 456, September




(PDF 0-2 workdays service: $29.90)

Accession: 035985225

Download citation: RISBibTeXText



Related references

No evidence of increased risk for certain highly atherogenic lipoprotein phenotypes in HIV-infected patients. Archives of Medical Research 39(1): 84-91, 2007

Effects of CETP gene polymorphisms on atherogenic lipoprotein phenotypes in Koreans. Nutritional Sciences 6(2): 100-105, 2003

Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes. Journal of Endocrinological Investigation 30(7): 551-557, 2007

Lipoprotein(a) as a coronary risk factor in Japanese patients with Type II (non-insulin-dependent) diabetes mellitus. Relation with apolipoprotein(a) phenotypes. Diabetologia 41(11): 1397-1398, 1998

Genetics of the quantitative Lp(a) lipoprotein trait. I. Relation of LP(a) glycoprotein phenotypes to Lp(a) lipoprotein concentrations in plasma. Human Genetics 78(1): 41-46, 1988

Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease. Atherosclerosis 106(2): 149-157, 1994

The relation of lipoprotein concentrations and apolipoprotein phenotypes with asymptomatic atherosclerosis in subjects of the atherosclerosis risk in communities study. Arteriosclerosis & Thrombosis 13(11): 1558-1566, 1993

The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. Arteriosclerosis and Thrombosis 13(11): 1558-1566, 1993

The relation of lipoprotein(a) concentrations and apolipoprotein(a) phenotypes with asymptomatic atherosclerosis in subjects of the atherosclerosis risk in communities (ARIC) study. Arteriosclerosis and Thrombosis 13(11): 1558-1566, 1993

Lipoprotein metabolism and atherogenic risk. Zeitschrift für Medizinische Laboratoriumsdiagnostik 28(5): 235-239, 1987

High density lipoprotein particle size in children: relation to atherogenic dyslipidemia. Clinical Pediatric Endocrinology 13(1): 1-9, 2004

Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria. Clinical Chemistry 41(6 Pt 1): 908-913, 1995

Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients. Nephrology, Dialysis, Transplantation 10(9): 1668-1671, 1995

Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk. Metabolic Syndrome and Related Disorders 9(6): 411-418, 2012